Nixon J Scott 4

What Happened

• Nixon J. Scott, a director of USANA Health Sciences (USNA), had 1,057 restricted stock units (RSUs) convert into 1,057 shares on April 23, 2026. The filing shows a simultaneous disposition of 1,057 shares at $0.00 (reported as a derivative conversion/transaction).
• There are no cash proceeds reported from the disposition (amount reported $0). This transaction is not a market purchase; it reflects conversion/settlement of equity awards rather than an open-market buy or sale for cash.

Key Details

• Transaction date: April 23, 2026; Form 4 filed April 27, 2026 (covers the April 23 transaction).
• Converted: 1,057 RSUs → 1,057 shares (reported as derivative exercise/conversion).
• Disposed: 1,057 shares at $0.00 (proceeds reported $0).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: F1 — each RSU equals one share of USNA common stock; F2 — RSUs vested 25% on 7/24/2025, 10/23/2025, 1/22/2026 and 4/23/2026 (this transaction corresponds to the April 23, 2026 vesting).
• No 10b5-1 plan or late-filing flag is indicated in the provided details.

Context

• This is a conversion/settlement of vested restricted stock units, not an open-market sale or purchase. When RSUs vest, companies commonly either issue shares or withhold a portion of shares to cover taxes; a same-day disposition reported at $0 often reflects net settlement/withholding rather than a sale for cash.
• For retail investors: conversions of RSUs are routine compensation events and do not necessarily signal management’s view of the stock. Purchases (insider buys) carry more direct informational weight than routine vesting or withholding transactions.